SYRE
Common StockSpyre Therapeutics, Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$103.3M
Portfolio Weight
37.77%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$273.6M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
SYRE
Common StockSpyre Therapeutics, Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$103.3M
Portfolio Weight
37.77%
ORKA
Common StockOruka Therapeutics, Inc.
Reported Shares
954.2K
Position Mix
No options reported
Reported Value
$79.5M
Portfolio Weight
29.05%
DMRA
Common StockDamora Therapeutics, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$43.5M
Portfolio Weight
15.91%
JBIO
Common StockJade Biosciences, Inc.
Reported Shares
1.8M
Position Mix
No options reported
Reported Value
$25.4M
Portfolio Weight
9.28%
KRSA
Common StockKorsana Biosciences, Inc.
Reported Shares
518.5K
Position Mix
No options reported
Reported Value
$16.6M
Portfolio Weight
6.06%
CBIO
Common StockCRESCENT BIOPHARMA, INC.
Reported Shares
361.3K
Position Mix
No options reported
Reported Value
$5.3M
Portfolio Weight
1.93%